World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
10045
World Ranking
3982
National Ranking
1820

Jack J. Bleesing publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jack J. Bleesing sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jack J. Bleesing D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jack J. Bleesing sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jack J. Bleesing is affiliated with Cincinnati Children's Hospital Medical Center in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions to Immunology, Hematology, Genetics, Epidemiology, and Oncology subfields.

Their main research topics include:

  • Immunodeficiency and Autoimmune Disorders
  • Blood disorders and treatments
  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • Complement system in diseases
  • Autoimmune and Inflammatory Disorders Research
  • Renal Transplantation Outcomes and Treatments

Jack J. Bleesing has authored numerous papers, with recent publications including:

  • Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab, 2020, Blood
  • Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report, 2020, Blood
  • Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function, 2020, Blood
  • Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium, 2023, The Lancet
  • Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy, 2020, Journal of Clinical Immunology

The frequent venues where Bleesing's work is published are:

  • Blood
  • Journal of Clinical Immunology
  • Transplantation and Cellular Therapy
  • Biology of Blood and Marrow Transplantation
  • Journal of Allergy and Clinical Immunology

Among frequent collaborators are:

  • Rebecca Marsh
  • Stella M. Davies
  • Luigi D. Notarangelo
  • Sharat Chandra
  • Michael B. Jordan

Best Publications

  • Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy

    Bernice Lo;Kejian Zhang;Wei Lu;Lixin Zheng

  • Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

    Joao B. Oliveira;Jack J. Bleesing;Umberto Dianzani;Thomas A. Fleisher

  • A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant

  • Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

    Sonata Jodele;Stella M. Davies;Adam Lane;Jane Khoury

  • Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D

    Benjamin Chaigne-Delalande;Feng-Yen Li;Feng-Yen Li;Geraldine M. O’Connor;Marshall J. Lukacs

  • Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis with Alemtuzumab

    Rebecca A. Marsh;Carl E. Allen;Kenneth L. McClain;Joanna L. Weinstein

  • Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

    Rebecca A. Marsh;Gretchen Vaughn;Mi-Ok Kim;Dandan Li

  • XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease

    Rebecca A. Marsh;Lisa Madden;Brenda J. Kitchen;Rajen Mody

  • Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

    Federica Barzaghi;Laura Cristina Amaya Hernandez;Benedicte Neven;Silvia Ricci

  • Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

    Karen L. Bride;Karen L. Bride;Tiffaney Vincent;Tiffaney Vincent;Kim Smith-Whitley;Kim Smith-Whitley;Michele P. Lambert;Michele P. Lambert

  • Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab

    Sonata Jodele;Sonata Jodele;Christopher E Dandoy;Christopher E Dandoy;Adam Lane;Adam Lane;Benjamin L Laskin

  • Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome

    David T. Teachey;Robert Greiner;Alix Seif;Edward Attiyeh

  • Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency

    Jolan E. Walter;Lindsey B. Rosen;Krisztian Csomos;Jacob M. Rosenberg

  • Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency

    Andrew L. Snow;Rebecca A. Marsh;Scott M. Krummey;Philip Roehrs

  • Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

    Jack J. H. Bleesing;Margaret R. Brown;Stephen E. Straus;Janet K. Dale

  • SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

    Elie Haddad;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley

  • Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.

    Jack J.H. Bleesing;Stephen E. Straus;Thomas A. Fleisher

  • Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.

    Pierre L. Yong;John Boyle;Mark Ballow;Marcia Boyle

  • Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.

    Tamar S. Rubin;Kejian Zhang;Carrie Gifford;Adam Lane

  • Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes

    Rebecca A. Marsh;Kanchan Rao;Prakash Satwani;Kai Lehmberg

  • Introduction to flow cytometry.

    Gerald E Marti;Maryalice Stetler-Stevenson;Jack J.H Bleesing;Thomas A Fleisher

Frequent Co-Authors

Stella M. Davies
Stella M. Davies Cincinnati Children's Hospital Medical Center
Alexandra H. Filipovich
Alexandra H. Filipovich Cincinnati Children's Hospital Medical Center
Michael B. Jordan
Michael B. Jordan Cincinnati Children's Hospital Medical Center
Thomas A. Fleisher
Thomas A. Fleisher National Institutes of Health
Jennifer M. Puck
Jennifer M. Puck University of California, San Francisco
Jolan E. Walter
Jolan E. Walter University of South Florida
Morton J. Cowan
Morton J. Cowan University of California, San Francisco
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Sung-Yun Pai
Sung-Yun Pai National Institutes of Health
Sharon E. Straus
Sharon E. Straus University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nurses aiming to specialize further might consider an fnp to acnp bridge program online, which helps bridge Family Nurse Practitioner skills to Acute Care specialties. This pathway supports advanced clinical roles focused on complex patient care.

Accelerated options are also available for professionals seeking quicker entry into nursing roles. Programs like the accelerated fnp enable students to complete Family Nurse Practitioner degrees efficiently, often appealing to those with prior healthcare experience.

For those coming from non-nursing backgrounds but interested in clinical practice, online bsn programs for non nurses offer flexible routes to earning a Bachelor of Science in Nursing. These programs are designed to accommodate career changers looking to build foundational nursing knowledge alongside immunology insights.

Moreover, identifying accelerated nursing programs that have less competitive admissions can be beneficial for those eager to enter the nursing workforce swiftly. Such programs balance rigorous training with accessible entry points, supporting timely progression into immunology-related nursing roles.

Best Scientists Citing Jack J. Bleesing

Trending Scientists